
NAPA, Calif., May 31 (UPI) -- U.S. firm Dey said Thursday its marketing partner Critical Therapeutics has been approved to sell Zyflo CR for asthma in patients 12 years and older.
The controlled-release tablets -- the first U.S.-approved leukotriene synthesis inhibitor -- have been approved for twice-daily prevention and chronic treatment of asthma, the company said.
Pursuant to a deal struck by the companies in March, Dey will co-market the drug with Critical Therapeutics.
Dey said the new treatment is not indicated for use in the reversal of bronchospasm in acute asthma attacks but can be continued during acute exacerbations of the condition.
Zyflo goes after leukotrienes, the inflammatory mediators responsible for asthma symptoms like inflammation, swelling and bronchoconstriction. The therapy uses SkyePharma's drug-delivery technology, which controls the amount and rate of drug released into the body, Dey said.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, May 27 (UPI) --
President Obama has put U.S. foreign policy on auto-pilot while he concentrates on getting re-elected, a senior Republican senator said Sunday.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption